Downloadable Living Slideset

Share

Program Content

Activities

  • HER2-Targeted Therapy in NSCLC
    Improving Outcomes for Patients With Advanced NSCLC Through the Optimal Integration of HER2-Targeted Antibody–Drug Conjugate Therapy
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 25, 2023

Faculty

cover img faculity

Lyudmila Bazhenova, MD

Lung Cancer Unit Leader
Director 
Hematology and Oncology Training Program
University of California 
San Diego, California

cover img faculity

Karen Reckamp, MD, MS

Director, Division of Medical Oncology
Associate Director of Clinical Research
Professor of Medicine
Cedars Sinai
Los Angeles, California

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.